Women's Health & OB/GYN
OB/GYN group practices, fertility clinics, maternal-fetal medicine programs, and women's health platforms.
- 4
- Verticals
Overview
Women's Health & OB/GYN covers OB/GYN group practices, fertility clinics, maternal-fetal medicine, and women's-health platforms. Most OB/GYN care sits within general physician offices, while fertility (IVF) has been a standout high-growth, cash-pay, and heavily consolidated sub-segment.
Demand is supported by women's-health awareness, delayed childbearing (fertility), and the consolidation of independent OB/GYN practices under MSO platforms (Unified Women's Healthcare, Axia, Ob Hospitalist Group). Fertility in particular has drawn intense private-equity interest.
Market snapshot
- Market size
- ~$4.6B
- Growth
- ~9.2%CAGR (2017–22, nominal)
- Companies
- ~2,700
U.S. Census Bureau 2022 CBP/Economic Census, NAICS 621410 (Family Planning Centers) — a small slice; most OB/GYN care sits within physician offices (621111).
Business model & economics
- Revenue model
- Reimbursed OB/GYN care plus cash-pay fertility
- Recurring revenue
- Moderate — recurring women's-health relationships
- EBITDA margin
- 15–25%; fertility higher
- Capex intensity
- Moderate
- Fertility (IVF) the high-growth, cash-pay sub-segment.
- MSO consolidation of OB/GYN practices.
- Delayed childbearing and awareness drive demand.
M&A deal context
Who’s acquiring
What’s driving deals
- Fertility-network roll-up.
- OB/GYN practice consolidation.
- Cash-pay fertility demand.
Verticals in this segment
- 4.10.29.1Fertility & Reproductive Medicine
IVF clinics and reproductive endocrinology practices.
- 4.10.29.2Maternal-Fetal Medicine Programs
High-risk obstetrics programs managing complicated pregnancies.
- 4.10.29.3OB/GYN Group Practices
Multi-physician obstetrics and gynecology group practices.
- 4.10.29.4Women's Health Platforms & Networks
PE-backed platforms consolidating women's health practices.
Find Women's Health & OB/GYN acquisition targets
Search Acquisera’s index for companies classified under Women's Health & OB/GYN (4.10.29) and build a targeted deal pipeline.
Search companies